Serenity Pharmaceuticals LLC

Serenity Pharmaceuticals LLC, is a privately held organization developing patented drugs for the pediatric and geriatric urology field.  They are in development and commercialization of Ser-120, a Phase III investigational drug currently in clinical development for the treatment of nocturia, a common yet often under-diagnosed disorder in adults characterized by frequent nighttime urination.